Dr. Millikan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 E 3RD ST ESSENTIA HEALTH DULUTH CLINIC
Duluth, MN 55805Phone+1 218-786-3625
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1988 - 1991
- University of Miami Leonard M. Miller School of MedicineClass of 1988
Certifications & Licensure
- IL State Medical License 2022 - 2026
- MN State Medical License 2013 - 2024
- WA State Medical License 2020 - 2023
- OR State Medical License 2020 - 2022
- UT State Medical License 2019 - 2022
- TX State Medical License 1994 - 2013
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2008
- America's Top Doctors for Cancer Castle Connolly, 2005-2007
Clinical Trials
- Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer Start of enrollment: 1996 Aug 01
- Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer Start of enrollment: 1997 Dec 01
- Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium Start of enrollment: 2001 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 60 citationsA phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in loc...Arlene O. Siefker-Radtke, Colin P.N. Dinney, Yu Shen, Dallas Williams, Ashish M. Kamat
Cancer. 2013-02-01 - 235 citationsFocus on bladder cancerColin P.N. Dinney, David J. McConkey, Randall E. Millikan, Xifeng Wu, Menashe Bar-Eli
Cancer Cell. 2004-08-01 - 39 citationsSurvival outcomes for men with mediastinal germ-cell tumors: The University of Texas M. D. Anderson Cancer Center experienceAlan J. Rodney, Nizar M. Tannir, Arlene O. Siefker-Radtke, Ping Liu, Garrett L. Walsh
Urologic Oncology. 2012-11-01
Other
- Experimental systemic therapy of metastatic bladder cancerMillikan RE
http://www.uptodate.com/contents/experimental-systemic-therapy-of-metastatic-bladder-cancer
UpToDate, Wolters Kluwer Health - 2012-09-25
Grant Support
- Neoadjuvant Therapy For Advanced Bladder CancerNational Cancer Institute1996–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: